Ivermectin research and development

Which cancers showed the strongest preclinical response to ivermectin and by what mechanisms?

Preclinical work identifies strongest anticancer signals for ivermectin in breast cancer, hematologic malignancies (notably leukemia), hepatocellular carcinoma, and several drug-resistant solid tumor ...